Target intelligence / Profile preview

Dicer–TAR RNA-binding protein complex (Dicer–TRBP complex) (Dicer–TRBP)

Target
Dicer–TRBP
Molecular classification
Enzyme, Ribonuclease III, RNA-binding protein complex
01

Overview

The Dicer–TAR RNA-binding protein complex (Dicer–TRBP complex) is a multi-protein assembly central to the RNA interference (RNAi) pathway, primarily responsible for the maturation of microRNAs (miRNAs) and small interfering RNAs (siRNAs). This complex is composed of the Dicer enzyme (DICER1), which contains two catalytic RNAse III domains, and the TAR RNA-binding protein (TRBP or TARBP2), which stabilizes Dicer and facilitates the efficient processing of precursor RNAs (UniProt Q9UPY3, Q15633). By converting precursor miRNAs (pre-miRNAs) into mature functional molecules, the complex regulates the post-transcriptional silencing of thousands of messenger RNAs (mRNAs) involved in development, cell proliferation, and apoptosis (PubMed 15973355). In various human cancers, the Dicer–TRBP complex is often dysregulated or mutated, leading to a global reduction in miRNA levels that can drive tumor progression and metastasis (PubMed 24508333). Additionally, the complex plays a role in viral infections, such as HIV-1, where it can be targeted or hijacked to influence viral replication. Therapeutic interest in this complex involves small molecules like enoxacin, which acts as a Dicer activator to restore miRNA biogenesis in cancer cells (PubMed 18347094). However, pharmacological modulation of this complex carries significant safety risks, as non-specific interference with the RNAi machinery can lead to widespread gene dysregulation and systemic toxicity.

Other names
DICER1–TARBP2 complexDicer–TRBP holoenzymeRISC-loading complex component
02

Mechanism of action

Enhancement of Dicer-mediated processing of precursor microRNAs (pre-miRNAs) into mature microRNAs (miRNAs) (PubMed 18347094); stabilization of the Dicer-TRBP interaction to improve catalytic efficiency.

03

Biological functions

miRNA processingRNA interferenceGene silencingViral defense
04

Disease associations

CancerViral infectionNeurodegenerative disease
05

Safety considerations

Global disruption of miRNA biogenesisOff-target gene silencingPotential for systemic toxicity due to interference with essential cellular RNAi pathways
06

Interacting drugs

Enoxacin

1 more in the full profile.

07

Biomarkers

miRNA expression profilesDICER1 mutation statusTARBP2 expression levels

Beyond the preview

Go deeper on Dicer–TAR RNA-binding protein complex (Dicer–TRBP complex) (Dicer–TRBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dicer–TAR RNA-binding protein complex (Dicer–TRBP complex) (Dicer–TRBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call